Zimmer Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-28,700
Closed -$1.02M 134
2023
Q4
$1.02M Buy
28,700
+13,700
+91% +$487K 0.04% 92
2023
Q3
$446K Buy
+15,000
New +$446K 0.01% 113
2018
Q4
Sell
-10,000
Closed -$287K 81
2018
Q3
$287K Buy
+10,000
New +$287K ﹤0.01% 92